Trends in Patch Testing with the Mayo Clinic Standard Series, 2017–2021
Dermatitis® · 01.10.2023 · 34 (5) · 405-412
DOI: 10.1089/derm.2023.0063 ↗Kurz gefasst
Fachartikel in der Zeitschrift Dermatitis®, online erschienen am 15.09.2023. Verfasst von Suha Zawawi und 7 weiteren Autor:innen. Beteiligte Einrichtung: From the Department of Dermatology, Mayo Clinic Florida, Jacksonville, Florida, USA. Hauptthemen laut MEDLINE: Dermatitis, Allergic Contact. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 16 Literaturangaben.
Abstract (Originalsprache)
Background
Patch testing to a standard series is used to identify culprit allergens in patients with contact dermatitis. The reaction rates evolve over time based on trends in cutaneous exposures by the general population.
Objective
The aim of this study was to analyze the patch test results of the Mayo Clinic standard series in patients tested from 2017 to 2021.
Methods
The patch test reactions of standard series allergens tested from 2017 to 2021 were retrospectively reviewed and compared with the results of our prior report from 2011 to 2015 as well as the North American Contact Dermatitis Group (NACDG) report from 2017 to 2018.
Results
Of 2667 patients tested, 1683 (63.1%) had at least 1 positive reaction. The 15 allergens with the highest reaction rates were hydroperoxides of linalool 1%, nickel (II) sulfate hexahydrate, methylisothiazolinone, Myroxylon pereirae resin, hydroperoxides of linalool 0.5%, methyldibromo glutaronitrile, neomycin sulfate, cobalt (II) chloride hexahydrate, fragrance mix I, benzalkonium chloride, bacitracin, hydroperoxides of limonene, methylchloroisothiazolinone/methylisothiazolinone, p-phenylenediamine, and textile dye mix. Twelve (80%) of these allergens were also in the top 15 of the most recent NACDG report.
Conclusions
Hydroperoxides of linalool and hydroperoxides of limonene are new allergens that have been added to our standard series. These are associated with high reaction rates.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- From the Department of Dermatology, Mayo Clinic Florida, Jacksonville, Florida, USA.
- Department of Dermatology, Mayo Clinic Arizona, Scottsdale, Florida, USA; and.
- Department of Dermatology, Mayo Clinic, Rochester, Minnesota, USA.
ORCID-Profile: Yul W Yang, Matthew R Hall
Zitieren
APA
Zawawi, S., Yang, Y. W., Cantwell, H. M., Drage, L. A., Youssef, M. J., Yiannias, J. A., Davis, M. D. P., & Hall, M. R. (2023). Trends in Patch Testing with the Mayo Clinic Standard Series, 2017–2021. Dermatitis®, 34(5), 405-412. https://doi.org/10.1089/derm.2023.0063
Vancouver
Zawawi S, Yang YW, Cantwell HM, Drage LA, Youssef MJ, Yiannias JA, et al. Trends in Patch Testing with the Mayo Clinic Standard Series, 2017–2021. Dermatitis®. 2023;34(5):405-412. doi:10.1089/derm.2023.0063
BibTeX
@article{Zawawi2023,
author = {Zawawi, Suha and Yang, Yul W and Cantwell, Hafsa M and Drage, Lisa A and Youssef, Molly J and Yiannias, James A and Davis, Mark D P and Hall, Matthew R},
title = {Trends in Patch Testing with the Mayo Clinic Standard Series, 2017–2021},
journal = {Dermatitis®},
year = {2023},
volume = {34},
number = {5},
pages = {405--412},
doi = {10.1089/derm.2023.0063}
}
EUVIMED